BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 3308413)

  • 1. New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.
    Reilly CS; Nimmo WS
    Drugs; 1987 Jul; 34(1):98-135. PubMed ID: 3308413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atracurium: neuromuscular blockade in repeated administration].
    Kube D; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):639-44. PubMed ID: 2869712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular block monitoring after the administration of 1 mg/kg intravenous cis-atracurium in the anaesthetized pig.
    Aguilar A; Moll X; García F; Andaluz A
    J Vet Pharmacol Ther; 2019 Jan; 42(1):67-73. PubMed ID: 30125948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular and cardiovascular effects of atracurium in ponies anesthetized with halothane.
    Hildebrand SV; Howitt GA; Arpin D
    Am J Vet Res; 1986 May; 47(5):1096-100. PubMed ID: 3755016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepines and neuromuscular blocking drugs in patients.
    Driessen JJ; Crul JF; Vree TB; van Egmond J; Booij LH
    Acta Anaesthesiol Scand; 1986 Nov; 30(8):642-6. PubMed ID: 2880446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia.
    Foldes FF; Nagashima H; Boros M; Tassonyi E; Fitzal S; Agoston S
    Br J Anaesth; 1983; 55 Suppl 1():97S-103S. PubMed ID: 6190489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular and cardiovascular effects of atracurium administered to healthy horses anesthetized with halothane.
    Hildebrand SV; Arpin D
    Am J Vet Res; 1988 Jul; 49(7):1066-71. PubMed ID: 3421529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atracurium infusion in total intravenous anesthesia.
    Nilsson A; Tamsen A; Persson MP
    Acta Anaesthesiol Scand; 1987 Apr; 31(3):205-7. PubMed ID: 2437753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical assessment of atracurium using the single twitch and tetanic responses of the adductor pollicis muscles.
    Hughes R; Payne JP
    Br J Anaesth; 1983; 55 Suppl 1():47S-52S. PubMed ID: 6688017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function.
    Vandenbrom RH; Wierda JM; Agoston S
    Clin Pharmacokinet; 1990 Sep; 19(3):230-40. PubMed ID: 2394062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of neuromuscular blocking agents.
    Fisher DM
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.
    Jaklitsch RR; Westenskow DR
    J Clin Monit; 1990 Jan; 6(1):24-38. PubMed ID: 2404085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular blocking properties of atracurium during sevoflurane or propofol anaesthesia in dogs.
    Kastrup MR; Marsico FF; Ascoli FO; Becker T; Soares JH; Gomez de Segura IA
    Vet Anaesth Analg; 2005 Jul; 32(4):222-7. PubMed ID: 16008719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in neuromuscular blocking agents.
    Bartkowski RR
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S14-7. PubMed ID: 10437712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.